@article{1f0d9b67c82c429bb6a3d58d1d5131ea,
title = "Luspatercept use for lower risk myelodysplastic syndromes: Active but not enough",
author = "Patnaik, {Mrinal M.} and Ayalew Tefferi",
note = "Funding Information: Mrinal M. Patnaik has received research funding from Kura Oncology, Stem Line pharmaceuticals, Epigenetix, and CITI pharmaceuticals. ",
year = "2023",
month = aug,
doi = "10.1002/ajh.27003",
language = "English (US)",
volume = "98",
pages = "1171--1175",
journal = "American journal of hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "8",
}